SE416545B - Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat - Google Patents

Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Info

Publication number
SE416545B
SE416545B SE7611125A SE7611125A SE416545B SE 416545 B SE416545 B SE 416545B SE 7611125 A SE7611125 A SE 7611125A SE 7611125 A SE7611125 A SE 7611125A SE 416545 B SE416545 B SE 416545B
Authority
SE
Sweden
Prior art keywords
frnoxi
aminopropan
derivatives
procedure
active
Prior art date
Application number
SE7611125A
Other languages
English (en)
Swedish (sv)
Other versions
SE7611125L (sv
Inventor
E I Carlsson
G B R Samuelsson
B T Lundgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE7611125A priority Critical patent/SE416545B/xx
Priority to ZA00775603A priority patent/ZA775603B/xx
Priority to DE19772743493 priority patent/DE2743493A1/de
Priority to NZ185318A priority patent/NZ185318A/xx
Priority to AT702177A priority patent/AT351509B/de
Priority to AU29300/77A priority patent/AU516727B2/en
Priority to NL7710941A priority patent/NL7710941A/xx
Priority to FI772936A priority patent/FI772936A/fi
Priority to DD7700201371A priority patent/DD132195A5/xx
Priority to HU77HE752A priority patent/HU177638B/hu
Priority to CS776486A priority patent/CS208734B2/cs
Priority to FR7730156A priority patent/FR2367054A1/fr
Priority to NO773406A priority patent/NO145436C/no
Priority to GB41699/77A priority patent/GB1589838A/en
Priority to CA288,290A priority patent/CA1093096A/en
Priority to CS776486A priority patent/CS208731B2/cs
Priority to LU78263A priority patent/LU78263A1/xx
Priority to CS776486A priority patent/CS208730B2/cs
Priority to CS776486A priority patent/CS208732B2/cs
Priority to DK443177A priority patent/DK145375C/da
Priority to SU772528198A priority patent/SU735166A3/ru
Priority to CS776486A priority patent/CS208733B2/cs
Priority to IE2046/77A priority patent/IE45938B1/en
Priority to BE181531A priority patent/BE859474A/xx
Priority to JP12133477A priority patent/JPS5346928A/ja
Priority to CH1230577A priority patent/CH636337A5/de
Publication of SE7611125L publication Critical patent/SE7611125L/xx
Priority to SU782640402A priority patent/SU784760A3/ru
Priority to SU782641105A priority patent/SU959623A3/ru
Priority to AT671878A priority patent/AT353250B/de
Priority to AT671778A priority patent/AT353249B/de
Priority to US06/027,279 priority patent/US4263323A/en
Priority to AT378179A priority patent/AT363067B/de
Publication of SE416545B publication Critical patent/SE416545B/xx
Priority to CH702981A priority patent/CH632986A5/de
Priority to CH703081A priority patent/CH632987A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7611125A 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat SE416545B (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
ZA00775603A ZA775603B (en) 1976-10-07 1977-09-19 Heart active compounds
DE19772743493 DE2743493A1 (de) 1976-10-07 1977-09-28 Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel
NZ185318A NZ185318A (en) 1976-10-07 1977-10-03 Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions
AT702177A AT351509B (de) 1976-10-07 1977-10-03 Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1-phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
AU29300/77A AU516727B2 (en) 1976-10-07 1977-10-04 Phenoxy alkylamines
NL7710941A NL7710941A (nl) 1976-10-07 1977-10-05 Hart-actieve verbindingen.
FI772936A FI772936A (fi) 1976-10-07 1977-10-05 Foerfarande foer framstaellning av fenoxihydroxipropylaminer med blockerande verkan pao hjaertats beta-reseptorer
DD7700201371A DD132195A5 (de) 1976-10-07 1977-10-05 Verfahren zur herstellung von aminen
HU77HE752A HU177638B (en) 1976-10-07 1977-10-05 Process for producing 3-bracket-2-phenoxy-ethyl-amino-bracket-1-phenoxy-propanoles
CS776486A CS208730B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
FR7730156A FR2367054A1 (fr) 1976-10-07 1977-10-06 Derives ortho et n- substitues de phenoxy-amino-propanol et leur application comme composes cardiotoniques
NO773406A NO145436C (no) 1976-10-07 1977-10-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive aminer.
GB41699/77A GB1589838A (en) 1976-10-07 1977-10-06 1-phenoxy-3-amino-propan-2-ols
CA288,290A CA1093096A (en) 1976-10-07 1977-10-06 Heart active derivatives of 1-amino-2,3-dihydroxy propane
CS776486A CS208731B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
LU78263A LU78263A1 (cs) 1976-10-07 1977-10-06
CS776486A CS208734B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208732B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
DK443177A DK145375C (da) 1976-10-07 1977-10-06 Analogifremgangsmaade til fremstilling af fenoxypropanolaminereller salte deraf
SU772528198A SU735166A3 (ru) 1976-10-07 1977-10-06 Способ получени производных амина или их солей
CS776486A CS208733B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
IE2046/77A IE45938B1 (en) 1976-10-07 1977-10-06 1-phenoxy-3-amino-propan-2-ols
BE181531A BE859474A (fr) 1976-10-07 1977-10-07 Composes actifs pour le coeur
JP12133477A JPS5346928A (en) 1976-10-07 1977-10-07 Novel heart active compound and process for preparation thereof
CH1230577A CH636337A5 (en) 1976-10-07 1977-10-07 Process for preparing novel amines having beta receptor-inhibiting activity
SU782640402A SU784760A3 (ru) 1976-10-07 1978-07-28 Способ получени производных амина или их солей
SU782641105A SU959623A3 (ru) 1976-10-07 1978-07-28 Способ получени производных амина
AT671878A AT353250B (de) 1976-10-07 1978-09-18 Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1- phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
AT671778A AT353249B (de) 1976-10-07 1978-09-18 Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1- phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
US06/027,279 US4263323A (en) 1976-10-07 1979-04-05 β-Receptor blocking compounds and treatment of cardiovascular disorders therewith
AT378179A AT363067B (de) 1976-10-07 1979-05-23 Verfahren zur herstellung von neuen 3-phenoxy-2-hydroxy-1-phenoxy- oder -1-phenylthioalkylamino-propanen und von deren saeureadditionssalzen
CH702981A CH632986A5 (en) 1976-10-07 1981-11-03 Process for preparing novel amines
CH703081A CH632987A5 (en) 1976-10-07 1981-11-03 Process for preparing novel amines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Publications (2)

Publication Number Publication Date
SE7611125L SE7611125L (sv) 1978-04-08
SE416545B true SE416545B (sv) 1981-01-19

Family

ID=20329066

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Country Status (22)

Country Link
JP (1) JPS5346928A (cs)
AT (1) AT351509B (cs)
AU (1) AU516727B2 (cs)
BE (1) BE859474A (cs)
CA (1) CA1093096A (cs)
CH (1) CH636337A5 (cs)
CS (5) CS208734B2 (cs)
DD (1) DD132195A5 (cs)
DE (1) DE2743493A1 (cs)
DK (1) DK145375C (cs)
FI (1) FI772936A (cs)
FR (1) FR2367054A1 (cs)
GB (1) GB1589838A (cs)
HU (1) HU177638B (cs)
IE (1) IE45938B1 (cs)
LU (1) LU78263A1 (cs)
NL (1) NL7710941A (cs)
NO (1) NO145436C (cs)
NZ (1) NZ185318A (cs)
SE (1) SE416545B (cs)
SU (3) SU735166A3 (cs)
ZA (1) ZA775603B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
JPH0627370B2 (ja) * 1985-08-23 1994-04-13 日本エステル株式会社 ポリエステル異形断面太細糸
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE590054A (fr) * 1959-04-22 1960-10-24 Pfizer Alkylamines et leur préparation.
GB1264128A (cs) * 1968-06-29 1972-02-16
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
ATA702177A (de) 1979-01-15
SU735166A3 (ru) 1980-05-15
SE7611125L (sv) 1978-04-08
NL7710941A (nl) 1978-04-11
CS208730B2 (en) 1981-09-15
NO145436B (no) 1981-12-14
SU959623A3 (ru) 1982-09-15
CA1093096A (en) 1981-01-06
DK145375C (da) 1983-04-11
DK145375B (da) 1982-11-08
ZA775603B (en) 1978-06-28
FR2367054A1 (fr) 1978-05-05
NZ185318A (en) 1980-02-21
DD132195A5 (de) 1978-09-06
CS208734B2 (en) 1981-09-15
CS208732B2 (en) 1981-09-15
HU177638B (en) 1981-11-28
BE859474A (fr) 1978-04-07
JPS5346928A (en) 1978-04-27
NO145436C (no) 1982-03-24
NO773406L (no) 1978-04-10
CS208731B2 (en) 1981-09-15
AT351509B (de) 1979-07-25
IE45938L (en) 1978-04-07
LU78263A1 (cs) 1978-06-09
SU784760A3 (ru) 1980-11-30
CH636337A5 (en) 1983-05-31
FR2367054B1 (cs) 1981-11-06
CS208733B2 (en) 1981-09-15
DE2743493A1 (de) 1978-04-13
DK443177A (da) 1978-04-08
IE45938B1 (en) 1983-01-12
GB1589838A (en) 1981-05-20
AU2930077A (en) 1979-04-12
FI772936A (fi) 1978-04-08
AU516727B2 (en) 1981-06-18

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE442400B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE7703715L (sv) Framstellning av nya aminokromanoler
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE441359B (sv) Forfarande for framstellning av nya klavulansyratioetrar
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE425493B (sv) Forfarande for framstellning av nya estrar av testosteron
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE7703634L (sv) Forfarande for framstellning av nya amidinopenicillanoyloxialkylamoxicillinater
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
FI773846A (fi) Foerfarande foer framstaellning av nya sulfamoylbentsoesyror
SE435715B (sv) Forfarande for framstellning av nya penicilliner
SE416545B (sv) Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE431655B (sv) Analogiforfaranden for framstellning av nya 9-klorprednisolon-derivat
SE442866B (sv) Forfarande for framstellning av nya arylalkylaminer